REZOLUTE, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
REZOLUTE, INC. (RZLT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$195.38 thousand for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-22.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-09-22
- REZOLUTE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$82.58K.
- REZOLUTE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$27.71K.
- REZOLUTE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$24.06K.
- REZOLUTE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$61.02K.
- REZOLUTE, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$195.38K.
- REZOLUTE, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$1.45M.
- REZOLUTE, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$3.61M.
- REZOLUTE, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$830.18K, a 548.47% decline from fiscal 2013.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$82.58K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-22 | -$110.30K derived: sum of 2 quarters · filed 2017-09-22 | -$134.36K derived: sum of 3 quarters · filed 2017-09-22 | -$195.38K 10-K · filed 2017-09-22 |
| 2017-03-31 | -$27.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$51.78K derived: sum of 2 quarters · filed 2017-05-15 | -$112.80K 10-Q · filed 2017-05-15 | -$430.18K derived: sum of 4 quarters · filed 2017-09-22 |
| 2016-12-31 | -$24.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-02 | -$85.09K 10-Q · filed 2017-02-02 | -$402.46K derived: sum of 3 quarters · filed 2017-09-22 | -$919.34K derived: sum of 4 quarters · filed 2017-09-22 |
| 2016-09-30 | -$61.02K 10-Q · filed 2016-11-14 | -$378.40K derived: sum of 2 quarters · filed 2017-09-22 | -$895.27K derived: sum of 3 quarters · filed 2017-09-22 | -$1.13M derived: sum of 4 quarters · filed 2017-09-22 |
| 2016-06-30 | -$317.38K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-22 | -$834.25K derived: sum of 2 quarters · filed 2017-09-22 | -$1.07M derived: sum of 3 quarters · filed 2017-09-22 | -$1.45M 10-K · filed 2017-09-22 |
| 2016-03-31 | -$516.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$747.86K derived: sum of 2 quarters · filed 2017-05-15 | -$1.14M 10-Q · filed 2017-05-15 | -$3.37M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$230.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-02 | -$619.88K 10-Q · filed 2017-02-02 | -$2.85M derived: sum of 3 quarters · filed 2017-02-02 | -$3.91M derived: sum of 4 quarters · filed 2017-02-02 |
| 2015-09-30 | -$388.88K 10-Q · filed 2016-11-14 | -$2.62M derived: sum of 2 quarters · filed 2016-11-14 | -$3.68M derived: sum of 3 quarters · filed 2016-11-14 | -$3.83M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | -$3.29M derived: sum of 2 quarters · filed 2016-09-28 | -$3.45M derived: sum of 3 quarters · filed 2016-09-28 | -$3.61M 10-K · filed 2016-09-28 |
| 2015-03-31 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-16 | -$1.21M derived: sum of 2 quarters · filed 2016-05-16 | -$1.38M 10-Q · filed 2016-05-16 | -$2.20M derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | -$153.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | -$321.04K 10-Q · filed 2016-02-16 | -$1.14M derived: sum of 3 quarters · filed 2016-02-16 | -$1.14M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-09-30 | -$168.04K 10-Q · filed 2015-11-16 | -$988.01K derived: sum of 2 quarters · filed 2015-11-16 | -$991.39K derived: sum of 3 quarters · filed 2015-11-16 | -$994.77K derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | -$819.97K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | -$823.35K derived: sum of 2 quarters · filed 2015-09-28 | -$826.73K derived: sum of 3 quarters · filed 2015-09-28 | -$830.18K 10-K · filed 2015-09-28 |
| 2014-03-31 | -$3.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | -$6.76K derived: sum of 2 quarters · filed 2015-05-15 | -$10.21K 10-Q · filed 2015-05-15 | |
| 2013-12-31 | -$3.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | -$6.83K 10-Q · filed 2015-02-17 | ||
| 2013-09-30 | -$3.45K 10-Q · filed 2014-11-12 | |||
| 2013-06-30 | $185.11K 10-K · filed 2014-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |